Dissemination of Methicillin‐ResistantStaphylococcus aureusUSA300 Sequence Type 8 Lineage in Latin America
Open Access
- 15 December 2009
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 49 (12), 1861-1867
- https://doi.org/10.1086/648426
Abstract
Background.Methicillin-resistant Staphylococus aureus (MRSA) is an important nosocomial and community-associated (CA) pathogen. Recently, a variant of the MRSA USA300 clone emerged and disseminated in South America, causing important clinical problems. Methods.S. aureus isolates were prospectively collected (2006–2008) from 32 tertiary hospitals in Colombia, Ecuador, Peru, and Venezuela. MRSA isolates were subjected to antimicrobial susceptibility testing and pulsed-field gel electrophoresis and were categorized as health care-associated (HA)-like or CA-like clones on the basis of genotypic characteristics and detection of genes encoding Panton-Valentine leukocidin and staphylococcal cassette chromosome (SCC) mec IV. In addition, multilocus sequence typing of representative isolates of each major CA-MRSA pulsotype was performed, and the presence of USA300-associated toxins and the arcA gene was investigated for all isolates categorized as CA-MRSA. Results.A total of 1570 S. aureus were included; 651 were MRSA (41%)—with the highest rate of MRSA isolation in Peru (62%) and the lowest in Venezuela (26%)—and 71%, 27%, and 2% were classified as HA-like, CA-like, and non-CA/HA-like clones, respectively. Only 9 MRSA isolates were confirmed to have reduced susceptibility to glycopeptides (glycopeptide-intermediate S. aureus phenotype). The most common pulsotype (designated ComA) among the CA-like MRSA strains was found in 96% of isolates, with the majority (81%) having a ⩽6-band difference with the USA300-0114 strain. Representative isolates of this clone were sequence type 8; however, unlike the USA300-0114 strain, they harbored a different SCCmec IV subtype and lacked arcA (an indicator of the arginine catabolic mobile element). Conclusion.A variant CA-MRSA USA300 clone has become established in South America and, in some countries, is endemic in hospital settings.Keywords
This publication has 32 references indexed in Scilit:
- Novel Multiplex PCR Assay for Characterization and Concomitant Subtyping of Staphylococcal Cassette Chromosome mec Types I to V in Methicillin-Resistant Staphylococcus aureusJournal of Clinical Microbiology, 2005
- Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threatThe Lancet Infectious Diseases, 2005
- Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCCDrug Resistance Updates, 2003
- Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureusJournal of Clinical Microbiology, 2003
- Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002.Journal of Antimicrobial Chemotherapy, 2002
- Multiplex PCR Strategy for Rapid Identification of Structural Types and Variants of the mec Element in Methicillin-Resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2002
- Identification of a Novel Methicillin-Resistant Staphylococcus aureus Epidemic Clone in Córdoba, Argentina, Involved in Nosocomial InfectionsJournal of Clinical Microbiology, 2002
- Evaluation of Current Methods for Detection of Staphylococci with Reduced Susceptibility to GlycopeptidesJournal of Clinical Microbiology, 2001
- The Development of Vancomycin Resistance in a Patient with Methicillin-ResistantStaphylococcus aureusInfectionThe New England Journal of Medicine, 1999
- Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycinThe Lancet, 1997